AIPT - スカイライン・メディカル (Precision Therapeutics Inc.) スカイライン・メディカル



symbol AIPT
会社名 Precision Therapeutics Inc (スカイライン・メディカル)
分野(sector) Health Care   ヘルスケア
産業(industry) Industrial Specialties  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 Precision Therapeutics Inc. formerly Skyline Medical Inc. is a medical device company that develops and manufactures The STREAMWAY System a solution for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. The Company distributes these products to hospitals surgical centers and other medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained measured documented and disposed. The Company also manufactures and sells two disposable products required for system operation: a bifurcated single procedure filter and tissue trap and a single use bottle of cleaning solution. Both items are used on a single procedure basis. Its STREAMWAY Automated Surgical Fluid Waste Management System (FMS) is a wall mounted automated system that disposes of an unlimited amount of suctioned fluid from the patient using standard surgical tubing.   スカイライン・メディカルは米国の医療機器メ―カ―。主に、外科手術時や手術後における伝染物質を含む体液などを収集し処理するシステムを製造する。同社が特許を所有する「ストリ―ムウエイ」体液管理システムは、手術に使用される管から体液を吸引し容量を計測、使い捨てフィルタ―で収集し安全に廃棄する。本社はミネソタ州。   Precision Therapeutics, Inc. engages in the manufacture and distribution of healthcare products, and provision of related services. The company offers STREAMWAY System, which is an automated system for the collection and disposal of infectious fluids from surgical and other medical procedures. It operates through the Medical Device and Consumable Products segments. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN.
本社所在地 2915 Commers Drive Suite 900 Eagan MN 55121 USA
代表者氏名 Carl Schwartz カールシュワルツ
代表者役職名 President Chief Executive Officer Director 社長兼最高経営責任者(CEO)
電話番号 +1 651-389-4800
設立年月日 37347
市場名 NASDAQ Small Cap
ipoyear ―年
EBITDA EBITDA(百万ドル) -6.95743
終値(lastsale) 0.99
時価総額(marketcap) 13264355.61
時価総額 時価総額(百万ドル) 11.35509
売上高 売上高(百万ドル) 1.14303
企業価値(EV) 企業価値(EV)(百万ドル) 10.35161
当期純利益 当期純利益(百万ドル) -7.99458
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Precision Therapeutics Inc revenues increased from $282K to $770K. Net loss increased 6% to $4.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Sales and marketing expense increase from $379K to $1.1M (expense) Operations expense increase of 74% to $666K (expense).


 関連キーワード  (先端医療機器_テクノロジ― 米国株 スカイライン・メディカル AIPT Precision Therapeutics Inc.)


 twitter  (公式ツイッターやCEOツイッターなど)